Steroids and endometrial breakthrough bleeding: future directions for research.

Area of Science:

• Gynecology
• Reproductive Medicine
• Vascular Biology

Background:

• Abnormal endometrial bleeding is a significant issue for women using long-acting gestagens, reducing treatment adherence and quality of life.
• Previous research focused on epithelial-mesenchyme interactions, but recent studies shift focus to endometrial blood vessel structure and the endometrial environment.

Framework:

• Research is defining the expression of angiogenic inhibitors and stimulators.
• The critical roles of the endometrial matrix and immunocompetent cells are being elucidated.
• Simple estrogen supplementation yielded disappointing results.

Implementation:

• Future research should investigate women's attitudes towards vaginal bleeding in diverse cultural contexts.
• Studies are needed to educate women about bleeding patterns to improve acceptance of hormone replacement therapy.
• Molecular and cellular studies aim to define factors for healthy, non-leaky endometrial vessels.

Implications:

• Understanding pro- and anti-angiogenic agents and their interaction with matrix metalloproteinases is key for vessel integrity.
• Further research is required to understand neutrophil trafficking in the endometrium and its effect on bleeding.